Martin Thelen

Kerpener Str. 62
Koeln, NW 50937, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

IL-8-, IL-12-, and VEGF-producing peripheral blood mononuclear cells enable differentiation between vertebral osteomyelitis and degenerative spinal diseases.

IL-8-, IL-12-, and VEGF-producing peripheral blood mononuclear cells enable differentiation between vertebral osteomyelitis and degenerative spinal diseases.

Journal: Cytokine

Published: October 28, 2025

Local T-Cell Dysregulation and Immune Checkpoint Expression in Human Papillomavirus-Mediated Recurrent Respiratory Papillomatosis.

Local T-Cell Dysregulation and Immune Checkpoint Expression in Human Papillomavirus-Mediated Recurrent Respiratory Papillomatosis.

Journal: Cells

Published: May 19, 2025

Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD-1 Inhibition as Potential Treatment Option.

Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD-1 Inhibition as Potential Treatment Option.

Journal: Mycoses

Published: September 17, 2024

Long-Term Human Immune Reconstitution, T-Cell Development, and Immune Reactivity in Mice Lacking the Murine Major Histocompatibility Complex: Validation with Cellular and Gene Expression Profiles.

Long-Term Human Immune Reconstitution, T-Cell Development, and Immune Reactivity in Mice Lacking the Murine Major Histocompatibility Complex: Validation with Cellular and Gene Expression Profiles.

Journal: Cells

Published: September 09, 2024

Tertiary Lymphoid Structures in Pancreatic Cancer are Structurally Homologous, Share Gene Expression Patterns and B-cell Clones with Secondary Lymphoid Organs, but Show Increased T-cell Activation.

Tertiary Lymphoid Structures in Pancreatic Cancer are Structurally Homologous, Share Gene Expression Patterns and B-cell Clones with Secondary Lymphoid Organs, but Show Increased T-cell Activation.

Journal: Cancer immunology research

Published: March 28, 2024

Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides.

Germline homozygosity and allelic imbalance of HLA-I are common in esophagogastric adenocarcinoma and impair the repertoire of immunogenic peptides.

Journal: Journal for immunotherapy of cancer

Published: March 17, 2024

Multiparametric Characterization of the DSL-6A/C1 Pancreatic Cancer Model in Rats.

Multiparametric Characterization of the DSL-6A/C1 Pancreatic Cancer Model in Rats.

Journal: Cancers

Published: March 05, 2024

Co-expression patterns of cancer associated fibroblast markers reveal distinct subgroups related to patient survival in oropharyngeal squamous cell carcinoma.

Co-expression patterns of cancer associated fibroblast markers reveal distinct subgroups related to patient survival in oropharyngeal squamous cell carcinoma.

Journal: Frontiers in cell and developmental biology

Published: November 15, 2023

Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.

Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.

Journal: European journal of haematology

Published: October 24, 2023

Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma.

Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma.

Journal: Blood

Published: August 16, 2023

Corrigendum to 'Nivolumab induces long-term remission in a patient with fusariosis' [Eur J Cancer 173 (2022) 91-94].

Corrigendum to 'Nivolumab induces long-term remission in a patient with fusariosis' [Eur J Cancer 173 (2022) 91-94].

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 13, 2023

Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells.

Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells.

Journal: Journal for immunotherapy of cancer

Published: November 19, 2022

Showing 1-12 of 38

Last Updated: 09/26/2026